AVITA Medical: Q4 rev ~$17.6M, FY2025 $71.6M; new $60M credit facility; FY2026 guidance $80-85M

AVITA Medical, Inc.

2025-FY EPS reported -$1.74 revenue$71,610,000

Q4 2025 revenue ~$17.6M (vs $18.4M Q4 2024); Cohealyx-I fully enrolled, PermeaDerm-I >75% enrolled in Dec 2025.
FY2025 revenue $71.6M, up 11% YoY from $64.3M in 2024, within revised guidance.
FY2026 revenue guidance $80-85M (12-19% growth); TTM revenue covenant $68.5M for Q1 2026, $73M for FY2026.
New $60M credit facility with Perceptive Advisors ($50M funded, $10M option until Q1 2027); SOFR+7.5% (4% floor).
Warrant to purchase 500k shares (additional 150k if $10M drawn) at VWAP-based price; 10-year term; registration rights.

item 1.01 item 1.02 item 2.02 item 2.03 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

AVITA Medical, Inc. incurred credit facility of up to $60 million with Perceptive Credit Holdings V, LP at greater of (x) the SOFR rate for such period and (y) 4.00% plus, in either case, maturing five-year senior secured credit facility.

Instrument: credit facility
Principal: up to $60 million
Counterparty: Perceptive Credit Holdings V, LP
Rate: greater of (x) the SOFR rate for such period and (y) 4.00% plus, in either case,
Maturity: five-year senior secured credit facility
Event: incurrence

Exact text from the filing

Credit Agreement provides for a five-year senior secured credit facility in an aggregate principal amount of up to $60 million

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AVITA Medical, Inc. entered into Credit Agreement and Guaranty with Perceptive Credit Holdings V, LP valued at $60 million (effective 2026-01-13).

Action: entry
Agreement: credit facility
Counterparty: Perceptive Credit Holdings V, LP
Value: $60 million
Effective: 2026-01-13

Exact text from the filing

On January 13, 2026 (the “Closing Date”), AVITA Medical, Inc. (the “Company”) entered into a Credit Agreement and Guaranty (the “Credit Agreement”) and a Security Agreement (the “Security Agreement”), by and among the Company, as borrower, Avita Medical Americas, LLC, a wholly-owned subsidiary of the Company, as guarantor (the “Guarantor,” taken together with the Company, the “Obligors”) and Perceptive Credit Holdings V, LP as a lender and the administrative agent (the “Lender,” and the “Administrative Agent,” as applicable).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AVITA Medical, Inc. terminated Existing Credit Agreement with Lender under existing facility (effective 2026-01-13).

Action: termination
Agreement: credit facility
Counterparty: Lender under existing facility
Effective: 2026-01-13

Exact text from the filing

Simultaneously with the closing of the Initial Commitment Amount, the Company repaid in full and terminated all of its obligations and commitments (the “Refinancing Transaction”) under the Existing Credit Agreement (as defined below).

View on SEC.gov

306 debt financings filed in the last 30 days. Browse all debt financings →

AVITA Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-011167

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.